Cardiac biomarkers stand as crucial elements in the landscape of cardiovascular medicine, providing indispensable information about heart health. These biomarkers, often identifiable proteins released into the bloodstream in response to specific cardiac events, are instrumental in the diagnosis, prognosis, and ongoing monitoring of various cardiovascular conditions. While troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) remain prominent players in this domain, ongoing research strives to unveil new biomarkers that can offer even more nuanced insights into heart function. The continuous evolution of cardiac biomarker research contributes to a deeper understanding of cardiovascular diseases, paving the way for innovative diagnostic tools and personalized treatment approaches. As healthcare professionals delve into expanding the repertoire of cardiac biomarkers, they aim to enhance the precision of diagnoses and ultimately improve patient outcomes in the realm of cardiovascular care.
Title : Complete heart block and persistent left SVC: A pacing challenge after AV canal repair
Moataz Taha Mahmoud, Madinah Cardiac Center, Saudi Arabia
Title : Chemical detergent anionic surfactant-inducing dry cardiomyopathy (Yasser's cardiomyopathy) with parallel pupils/CXR phenomenon (Yasser's ophthalmic phenomenon), up-down Yasser's alternance, S1Q3 flat T3 pattern - Dramatic response to honey with possible cardiac regeneration - A case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Stabilization of molecular structures in red blood cell membrane by magnetite nanoparticles (ICNB) during storage
Andrey Belousov, Laboratory of Applied Nanotechnology of Belousov and Kharkiv National Medical University, Ukraine